Latest Ratios: P/E Ratio -0.5x · EV/EBITDA 104.4x · ROE N/A. (1998–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $988M | $1.2B | $1.5B | $3.5B | $3.7B | $8.4B | $3.6B | $5.9B | $9.7B | $10.5B | $8.4B |
| Enterprise Value | $12.7B | $62.0B | $60.3B | $49.2B | $45.0B | $53.9B | $12.6B | $14.6B | $42.2B | $41.8B | $38.0B |
| P/E Ratio → | -0.53 | — | — | — | — | 0.60 | — | — | 3.40 | 2.71 | — |
| P/S Ratio | 0.07 | 0.02 | 0.02 | 0.05 | 0.04 | 0.08 | 0.06 | 0.11 | 0.17 | 0.21 | 0.18 |
| P/B Ratio | — | — | — | 1.07 | 0.60 | 1.36 | — | 6.01 | 1.65 | 1.91 | 4.90 |
| P/FCF | — | — | — | — | 0.89 | 0.74 | 1.01 | — | 1.49 | 55.47 | 4.51 |
| P/OCF | — | — | 0.63 | — | 0.41 | 0.57 | 0.57 | 2.60 | 1.05 | 4.25 | 1.78 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.89 | 0.78 | 0.70 | 0.47 | 0.51 | 0.21 | 0.28 | 0.73 | 0.85 | 0.80 |
| EV / EBITDA | 104.38 | 98.14 | 12.65 | 14.25 | 4.15 | 1.72 | 1.22 | 3.84 | 3.70 | 3.37 | 4.31 |
| EV / EBIT | — | — | — | — | 13.34 | 2.55 | 1.82 | — | 6.81 | 4.91 | 15.00 |
| EV / FCF | — | — | — | — | 10.97 | 4.75 | 3.55 | — | 6.44 | 221.88 | 20.31 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 2.2% | 2.2% | 7.7% | 4.3% | 11.8% | 30.3% | 19.0% | 12.3% | 20.0% | 26.1% | 26.7% |
| Operating Margin | -5.7% | -5.7% | 1.3% | -2.5% | 6.3% | 25.7% | 12.0% | 0.3% | 14.3% | 19.0% | 12.5% |
| Net Profit Margin | -14.0% | -14.0% | -14.6% | -6.5% | -0.3% | 13.2% | -11.4% | -4.9% | 4.9% | 8.3% | -0.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | -97.6% | -5.5% | 512.3% | -5665.7% | -73.7% | 50.4% | 113.5% | -30.9% |
| ROA | -10.6% | -10.6% | -11.7% | -5.1% | -0.4% | 25.6% | -39.9% | -6.7% | 5.1% | 7.8% | -0.7% |
| ROIC | -6.0% | -6.0% | 1.5% | -2.7% | 9.2% | 68.0% | 58.8% | 0.5% | 16.6% | 20.6% | 13.2% |
| ROCE | -6.9% | -6.9% | 1.4% | -2.7% | 9.3% | 69.3% | 58.5% | 0.7% | 23.6% | 29.7% | 16.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | 18.27 | 8.81 | 8.74 | — | 11.24 | 6.42 | 6.42 | 21.08 |
| Debt / EBITDA | 112.90 | 112.90 | 15.47 | 17.33 | 4.96 | 1.73 | 1.13 | 2.90 | 3.34 | 2.84 | 4.12 |
| Net Debt / Equity | — | — | — | 13.94 | 6.77 | 7.34 | — | 8.87 | 5.49 | 5.73 | 17.19 |
| Net Debt / EBITDA | 96.28 | 96.28 | 12.32 | 13.23 | 3.81 | 1.45 | 0.87 | 2.29 | 2.85 | 2.53 | 3.36 |
| Debt / FCF | — | — | — | — | 10.08 | 4.01 | 2.54 | — | 4.95 | 166.41 | 15.81 |
| Interest Coverage | -0.68 | -0.68 | -0.19 | -0.41 | 1.01 | 6.63 | 9.73 | -2.07 | 2.78 | 3.61 | 1.18 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.76 | 0.76 | 1.31 | 1.53 | 1.42 | 1.56 | 1.20 | 1.44 | 0.93 | 0.94 | 0.71 |
| Quick Ratio | 0.50 | 0.50 | 0.83 | 1.02 | 0.85 | 0.91 | 0.91 | 0.97 | 0.56 | 0.58 | 0.48 |
| Cash Ratio | 0.29 | 0.29 | 0.59 | 0.78 | 0.61 | 0.48 | 0.62 | 0.68 | 0.24 | 0.23 | 0.32 |
| Asset Turnover | — | 0.85 | 0.76 | 0.77 | 1.10 | 1.14 | 3.53 | 3.09 | 0.98 | 0.93 | 0.92 |
| Inventory Turnover | 6.51 | 6.51 | 5.30 | 5.46 | 6.12 | 4.52 | 29.40 | 24.20 | 5.47 | 5.48 | 6.67 |
| Days Sales Outstanding | — | 43.10 | 16.80 | 29.11 | 20.83 | 37.15 | 9.57 | 7.95 | 19.35 | 24.31 | 12.51 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 0.4% | 0.2% | 36.8% | 71.3% | 0.1% | 11.4% | 15.4% | 9.6% | 23.7% |
| Payout Ratio | — | — | — | — | — | 42.9% | — | — | 52.3% | 24.5% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 166.3% | — | — | 29.4% | 36.9% | — |
| FCF Yield | — | — | — | — | 111.9% | 135.2% | 98.5% | — | 67.2% | 1.8% | 22.2% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.4% | 0.2% | 36.8% | 71.3% | 0.1% | 11.4% | 15.4% | 9.6% | 23.7% |
| Shares Outstanding | — | $399M | $399M | $398M | $399M | $399M | $398M | $398M | $398M | $398M | $398M |
Insolvency and Legal Liabilities
As reported in financial statements, Braskem's gross margin has compressed to a precarious 7.1% in 2026Q1, reflecting a persistent inability to pass through feedstock costs in a market environment where operating margins have frequently dipped into negative territory, most recently reaching -1.4% during the same period.
The company's profitability is currently dictated by severe spread compression between naphtha inputs and finished resin outputs, which renders the core industrial model unable to cover fixed overhead. Investors should note that the negative operating margins suggest that the current revenue base is insufficient to sustain the company's existing cost structure, necessitating a potential shift in operational scale.
Based on the company's reported figures, the cash conversion cycle has fluctuated significantly, reaching 41 days in 2026Q1, which indicates that the firm is struggling to maintain efficient inventory and receivables management amidst a broader environment of weakening demand and operational instability.
The increase in the cash conversion cycle suggests that Braskem is facing mounting difficulties in converting its inventory into cash, likely due to destocking trends among its customer base. This inefficiency, combined with the current asset turnover ratio of 0.20, implies that the company's capital-intensive asset base is failing to generate adequate revenue, further pressuring the firm's liquidity position.
According to recent SEC filings, Braskem's current ratio has tightened to 0.71 as of 2026Q1, signaling a diminished capacity to meet short-term obligations without relying on external financing or further depleting its already strained cash reserves during this period of sustained negative free cash flow.
The decline in the quick ratio to 0.40 highlights a heavy reliance on inventory liquidation to satisfy immediate liabilities, which is particularly concerning given the current cyclical downturn in the petrochemical sector. This liquidity profile warrants close monitoring, as any further deterioration could limit the company's operational flexibility and its ability to fund ongoing legal remediation efforts.
As indicated by the current TTM P/E of -0.53, the price-to-earnings ratio is a fundamentally misapplied metric for Braskem, as it fails to account for the massive, non-recurring legal provisions that currently distort the company's net income and obscure its underlying operational cash-generating potential.
Investors should prioritize enterprise-value-based metrics or normalized EBITDA, as the P/E ratio is rendered meaningless by the company's negative earnings and the volatility of its legal liabilities. Relying on earnings-based multiples in this context risks ignoring the structural cash burn and the significant impact of the Alagoas geological event on the firm's true economic value.
Includes 30+ ratios · 28 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BAK stock.
Braskem S.A.'s current P/E ratio is -0.5x. The historical average is 6.4x.
Braskem S.A.'s current EV/EBITDA is 104.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.1x.
Based on historical data, Braskem S.A. is trading at a P/E of -0.5x. Compare with industry peers and growth rates for a complete picture.
Braskem S.A. has 2.2% gross margin and -5.7% operating margin.
Braskem S.A.'s Debt/EBITDA ratio is 112.9x, indicating high leverage. A ratio above 4x may signal elevated financial risk.